Contribution
Absolutely, we are. I will set out what we are doing about pharmacy, but I thought it would be useful to reflect on the comments and contributions.
First, I want to address the issue of funding. As I said at the outset, the Government recognise the challenges facing community pharmacies following years of underfunding and the difficult fiscal environment. That is why, last year, we took the necessary decisions to give the sector a record 19% funding uplift across ’24-25 and ’25-26. I stress that, at the time, it was the NHS’s largest uplift. However, we know many pharmacies continue to face financial pressures, which is why we have followed last year’s settlement with a further significant uplift of 10% for ’26-27, worth an additional £340 million for the sector.
That funding will help to ensure that patients can continue to access medicines and important clinical support from community pharmacists. The uplift will also support the national roll-out of NHS pharmacist prescribing. From autumn ’26, those services will enable pharmacists to prescribe within the existing Pharmacy First and contraception service pathways, and for up to five new pathways. This will deliver increased access to NHS care, relieve pressures on other parts of the NHS and strengthen support in communities across England, delivering on the commitment made in our manifesto.
This year’s uplift is almost three times the rate of growth in the overall NHS budget and it demonstrates the priority the Government place on community pharmacy, but I do not pretend that the challenges will disappear overnight. Many pharmacies continue to face financial pressures, but the settlements represent a clear change in direction and provide the foundations for longer-term reform. Numerous Members raised pharmacy closures, and I can tell them that, according to recent data, there were 19 net closures in ’25-26 compared with 112 in ’24-25. There has been some progress, but I recognise that there is a lot more to do.
The long-term sustainability of community pharmacy depends on making better use of pharmacists’ clinical skills, reducing unnecessary administrative burdens and enabling pharmacists to deliver more care closer to people’s homes. We will deliver this through the three shifts set out in our 10-year health plan: sickness to prevention, analogue to digital, and hospital to community.
Let me give a clear example of how community pharmacy can support the shift from sickness to prevention. As a new Minister, I have already been struck by the vital role community pharmacists play in bringing vaccination services closer to the communities they serve. The NHS vaccination strategy and our 10-year health plan set out a clear ambition to increase vaccine uptake through primary care. That means complementing the core offer from general practice with accessible vaccination services in settings including maternity and sexual health services, schools, health visiting teams and, crucially, community pharmacy. During the ’25-26 flu programme, community pharmacists vaccinated approximately 4.7 million people, around 600,000 more than in the previous year. This demonstrates the growing contribution that pharmacists can make to prevention as a central part of the NHS-commissioned vaccine programme.
The shift from analogue to digital is very important. I am well aware that outdated technologies prevent skilled staff across the health and care sector, including pharmacy teams, from working to their full potential, stifling innovation and efficiency. Of course, digital transformation is not just about technology for its own sake; it is about giving pharmacists the tools they need to spend less time on admin and more time on caring for patients, and about giving patients more control over the care and support they receive.
Last year, a new prescription tracking service was introduced on the NHS app across nearly 1,500 community pharmacies in England. It allows patients to receive real-time updates and to check when their prescriptions are ready. This year, we will go further by strengthening the digital links between pharmacies and general practice as we build neighbourhood health teams in every community. Digital technology also has an important role to play in strengthening medicine supply chains, which is another issue raised today.
We also want prescribers to have better information about medicine shortages. At present, GPs cannot routinely see live national shortage information when prescribing. We intend to make that information available in real time to help GPs to prescribe suitable alternatives where necessary, saving time for patients and neighbourhood health teams. That will mean fewer patients going from pharmacy to pharmacy in search of medicines.
Thirdly, if we are serious about shifting care out of hospitals and into communities, community pharmacies must be part of the answer. They are trusted, accessible and highly valuable to the communities they serve. They have enormous potential.